Sars CoV2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
Active, not recruiting
  • SARS-CoV2
  • COVID-19
  • Assessing antibody responses, neutralizing capacity and memory B-cell function
  • Antwerpen, Belgium
  • +1 more
2021-12-07
Dec 7, 2021
M
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 - 2021
Terminated
  • Solid Tumor
  • +2 more
  • New York, New York
    Columbia University Irving Medical Center
2021-11-18
Nov 18, 2021
A
Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP - 2021
Completed
  • SARS-CoV2
  • Serology SARS-CoV2
  • Data collection
  • Paris, France
    Centre d'investigation clinique (CIC) Necker Cochin in Necker Ch
2021-11-19
Nov 19, 2021
N
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients - 2021
Completed
Has Results
  • Sars-CoV2
  • COVID
  • Newark, New Jersey
  • +5 more
2021-11-17
Nov 17, 2021
G
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) - 2021
Completed
  • COVID
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
2021-11-10
Nov 10, 2021
N
Incidence of COVID-19 Test Conversion in Post-surgical Patients - 2020
Completed
  • Sars-CoV2
  • COVID-19 PCR and Serology
  • Manhasset, New York
  • +1 more
2021-11-04
Nov 4, 2021
N
Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure - 2020
Terminated
  • Covid-19
  • Sars-CoV2
  • Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
  • Los Angeles, California
  • +1 more
2021-11-01
Nov 1, 2021
K
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
Recruiting
  • SARS (Severe Acute Respiratory Syndrome)
  • +5 more
  • Hyperbaric oxygen
  • Regensburg, Germany
  • +3 more
2021-11-05
Nov 5, 2021
U
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak
Recruiting
  • Sars-CoV2
  • Serological testing
  • Jette, Brussel, Belgium
    UZ Brussel
2021-11-03
Nov 3, 2021
P
Trial of Combination Therapy to Treat COVID-19 Infection
Active, not recruiting
  • COVID
  • +6 more
  • Ventura, California
    ProgenaBiome
2021-10-26
Oct 26, 2021
S
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19
Active, not recruiting
  • COVID-19
  • SARS-CoV2
  • SAB-185
  • Normal Saline
  • Miami Beach, Florida
  • +2 more
2021-10-25
Oct 25, 2021
S
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants
Active, not recruiting
  • COVID-19
  • SARS-CoV2
  • SAB-185
  • Normal saline
  • Wichita, Kansas
  • +2 more
2021-10-25
Oct 25, 2021
P
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
Recruiting
  • COVID-19
  • +7 more
  • Ventura, California
    ProgenaBiome
2021-10-19
Oct 19, 2021
B
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
Recruiting
  • Sars-CoV2
  • +2 more
  • Mesenchymal Stromal Cells
  • Supportive Care
  • Houston, Texas
    Houston Methodist Hospital
2021-09-29
Sep 29, 2021
M
Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection
Recruiting
  • SARS-CoV2
  • COVID
    • Rio De Janeiro, Brazil
    • +2 more
    2021-09-30
    Sep 30, 2021
    J
    Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection - 2021
    Terminated
    • Sars-CoV2
    • Peginterferon lambda alfa-1a subcutaneous injection
    • Saline
    • Baltimore, Maryland
      Johns Hopkins Hospital
    2021-09-24
    Sep 24, 2021
    U
    CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms
    Active, not recruiting
    • SARS-CoV2
    • Ribeirão Preto, SP, Brazil
    • +1 more
    2021-09-27
    Sep 27, 2021
    C
    SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)
    Recruiting
    • Covid-19
    • +4 more
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal (CHUM)
      2021-09-17
      Sep 17, 2021
      U
      Preventing COVID-19 Complications With Low- and High-dose Anticoagulation - 2021
      Terminated
      • COVID
      • Sars-CoV2
      • Geneva, Switzerland
      • +3 more
      2021-09-07
      Sep 7, 2021
      P
      A Study of Quintuple Therapy to Treat COVID-19 Infection
      Recruiting
      • COVID-19
      • +3 more
      • Ventura, California
        ProgenaBiome
      2021-09-02
      Sep 2, 2021
      T
      A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults
      Active, not recruiting
      • SARS-CoV2
      • Covid19
      • MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg
      • +3 more
      • Herston, Queensland, Australia
        Nucleus Network Brisbane (Q-Pharm Pty Ltd)
      2021-08-23
      Aug 23, 2021
      H
      Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection - 2020
      Completed
      • Sars-CoV2
      • ARDS
      • Lateral Position (left and right lateral decubitus)
      • Jesús María, Lima, Peru
        Hospital Rebagliati
      2021-08-23
      Aug 23, 2021
      P
      Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients - 2021
      Completed
      Has Results
      • COVID-19
      • Sars-CoV2
      • COVID-19 Convalescent Plasma (CCP)
      • Placebo
      • San Francisco, California
      • +2 more
      2021-08-23
      Aug 23, 2021
      I
      Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells - 2021
      Completed
      • COVID
      • +6 more
      • Allogenic pooled olfactory mucosa-derived mesenchymal stem cells
      • Standard treatment according to the Clinical protocols
      • Minsk, Belarus
        Institute of Biophysics and Cell Engineering of National Academy
      2021-08-20
      Aug 20, 2021
      U
      COVID-19 Brain Injury - 2021
      Completed
      • Sars-CoV2
      • +7 more
        • Pittsburgh, Pennsylvania
          University of Pittsburgh
        2021-08-13
        Aug 13, 2021